MRK vs BAX
By Alex · Tickerpine
Merck & Co., Inc. vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | BAX |
|---|---|---|
| Price | $145.27 | $25.30 |
| Market cap | $358.41B | $13.08B |
| P/E ratio | 117.2 | — |
| ROE | 6.96% | -14.37% |
| Profit margin | 4.77% | -9.27% |
| Revenue growth | 5.10% | 5.30% |
| Dividend yield | 2.34% | 0.16% |
| Beta | 0.22 | 0.65 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs BAX in plain English
- MRK is the bigger company — about 27.4× the market cap of BAX.
- MRK earns a higher return on equity (7% vs -14%).
- BAX is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.34% vs 0.16%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.